< Back to situations

[ORGANIZATION]

AbbVie Inc.

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [HEALTH] [US] [CA] [FR]

Biopharma financing and deals 2026

22 clusters · 49 sources · last updated

Latest: AbbVie Q2 2026 earnings beat forecasts and announces Apogee Therapeutics acquisition

Throughout H1 2026, biotech financing and M&A accelerated. Early July saw French Abivax raise $800 m, United Therapeutics acquire Thymmune for $140 m, Vertex agree to buy Crinetics for $10 bn, and a series of partnership

Also covered in